<DOC>
	<DOCNO>NCT00003006</DOCNO>
	<brief_summary>RATIONALE : Detecting early metastasis bone marrow and/or lymph node may help doctor plan good treatment non-small cell lung cancer . PURPOSE : Clinical trial detect presence metastatic cancer patient stage I non-small cell lung cancer previously treat .</brief_summary>
	<brief_title>Detection Early Metastases Patients With Stage I Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether presence occult micrometastases ( OM ) detect immunohistochemistry reverse transcriptase-polymerase chain reaction ( RT-PCR ) histologically negative lymph node bone marrow associate poor survival among patient stage I non-small cell lung cancer . - Determine incidence OM histologically negative lymph node bone marrow immunohistochemistry ( stain cytokeratins CEA glycoprotein ) RT-PCR ( detect CEA mRNA ) patient . - Assess sensitivity immunohistochemistry relative RT-PCR detecting OM patient . - Determine relationship tumor size ( T-stage ) presence OM detect immunohistochemistry RT-PCR patient . - Determine relationship presence OM disease-free survival patient . - Determine relationship site OM incidence recurrence , site recurrence , survival patient . OUTLINE : At time thoracotomy pulmonary resection , patient sample bone marrow , primary tumor , intrathoracic lymph node harvest . The presence occult metastases bone marrow lymph node assess use immunohistochemistry reverse transcriptase-polymerase chain reaction . Patients follow every 6 month 5 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Clinical stage I proven suspect new nonsmall cell lung carcinoma T1 T2 primary N1 N2 lymph node &lt; 1cm CT negative mediastinoscopy ≥ 5 year since prior chemo XRT ; prior mediastinal chest XRT . ≥ 18 year age No history previous lung cancer concomitant malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
</DOC>